Prawo i regulacje · 06/07/2022

DEA to Hold Hearing on Placement of 5 Tryptamines in Schedule I

The Drug Enforcement Administration will hold a hearing to discuss the proposed placement of five hallucinogenic tryptamines in Schedule I of the Controlled Substances Act, following an initial proposal published in the Federal Register on January 14, 2022.